CHARMM-GUI Covalent Ligand Docker as a Web-based Molecular Docking Platform for Covalent Ligands
Abstract
Covalent inhibitor research is an emerging topic in drug discovery due to its superior performance in specificity and inhibition effects. While molecular docking is a popular strategy in prediction and assessment of ligand conformations or poses in receptor proteins, covalent ligand docking requires nontrivial preparation efforts, as the ligand structure changes during the covalent complex formation. In order to facilitate molecular docking for covalent ligands, we have developed CHARMM-GUI Covalent Ligand Docker (CGUI-CLD), a new module for covalent ligand docking supported by AutoDock4. CGUI-CLD automates ligand preparation, supports ligand modification, implements docking simulation, and presents results through an intuitive user interface. A knowledge-based library built in CGUI-CLD currently supports 66 warheads and 8 amino acids, which can be used to automate the covalent ligand transformation from a pre-reaction to a post-reaction adduct form seamlessly. Moreover, CHARMM-GUI High-Throughput Simulator is integrated for rapid generation of multiple molecular dynamics simulation systems. CGUI-CLD is expected to significantly reduce a massive workload of covalent ligand docking and advance covalent ligand research. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=111 SRC="FIGDIR/small/738313v1_ufig1.gif" ALT="Figure 1"> View larger version (35K): org.highwire.dtl.DTLVardef@1b79576org.highwire.dtl.DTLVardef@1b579eforg.highwire.dtl.DTLVardef@1584d40org.highwire.dtl.DTLVardef@37bc02_HPS_FORMAT_FIGEXP M_FIG O_FLOATNOAbstract TOCC_FLOATNO C_FIG
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 Mpro inhibitor.
D. Zaidman, P. Gehrtz, … N. London·Cell Chemical BiologyPeer-reviewed·Dec 1, 2021
- Comparative Assessment of the Utility of Co-Folding and Docking for Small-Molecule Drug Design
Ute F. Röhrig, Marine Bugnon, Vincent Zoete·bioRxiv·Apr 20, 2026
- Attracting Cavities 3.0: Faster and More Versatile Molecular Docking for the SwissDock Webserver
Ute F. Röhrig, Marine Bugnon, Vincent Zoete·BioinformaticsPeer-reviewed·Jun 30, 2026
- High-efficiency discovery and structure-activity-relationship analysis of non-substrate-based covalent inhibitors of S-adenosylmethionine decarboxylase
Yuanbao Ai, Siyu Xu, … Sen Liu·Journal of Medicinal ChemistryPeer-reviewed·Jul 18, 2025
- LigandForge: A Web Server for Structure-Guided De Novo Drug Design
Hossam Nada, Levente Sipos-Szabó, … Moustafa Tarek Gabr·bioRxiv·Apr 3, 2026
- CANDOCK: Chemical atomic network based hierarchical flexible docking algorithm using generalized statistical potentials
J. A. Fine, J. Konc, … G. Chopra·bioRxiv·Jul 2, 2019